Cargando…
Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study
OBJECTIVES: To investigate health care utilisation including both primary and secondary health care 6 months before the diagnosis of a relapse or a second malignant neoplasm (SMN) in survivors of childhood acute lymphoblastic leukaemia (ALL). DESIGN AND SETTING: A Danish population-based matched coh...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378397/ https://www.ncbi.nlm.nih.gov/pubmed/34413108 http://dx.doi.org/10.1136/bmjopen-2021-050285 |
_version_ | 1783740826153648128 |
---|---|
author | Jensen, Karen Schow Klug Albertsen, Birgitte Schrøder, Henrik Zalounina Falborg, Alina Schmiegelow, Kjeld Rosthøj, Steen Callesen, Michael Thude Vedsted, Peter |
author_facet | Jensen, Karen Schow Klug Albertsen, Birgitte Schrøder, Henrik Zalounina Falborg, Alina Schmiegelow, Kjeld Rosthøj, Steen Callesen, Michael Thude Vedsted, Peter |
author_sort | Jensen, Karen Schow |
collection | PubMed |
description | OBJECTIVES: To investigate health care utilisation including both primary and secondary health care 6 months before the diagnosis of a relapse or a second malignant neoplasm (SMN) in survivors of childhood acute lymphoblastic leukaemia (ALL). DESIGN AND SETTING: A Danish population-based matched cohort study linking multiple nationwide registries. PARTICIPANTS: Participants were recruited from a total of 622 childhood ALL 2.5-year event-free survivors diagnosed between 1994 and 2015. Cases were survivors developing a relapse or an SMN and references were survivors still in first remission. Each case was matched with five references on age, sex, treatment protocol and risk group. PRIMARY OUTCOME MEASURES: Consultations in general practice and hospital the last 6 months before relapse or SMN. Cases and references were compared with monthly incidence rate ratios (IRRs) from negative binomial regression models. RESULTS: Of the 622 childhood ALL survivors, 60 (9.6%) developed a relapse (49) or an SMN (11) and 295 matched references were identified. Health care utilisation in general practice increased among cases the last month before the event compared with references with an IRR of 2.71 (95% CI 1.71 to 4.28). Data showed a bimodal structure with a significantly increased number of visits 4, 5 and 6 months before the event. Hospital health care utilisation increased 2 months before the event in cases with an IRR of 5.01 (3.78 to 6.63) the last month before the event and an IRR of 1.94 (1.32 to 2.85) the second-last month comparing cases and references. CONCLUSIONS: Survivors of childhood ALL developing a relapse or an SMN have a short period of increased health care utilisation before diagnosis. At hospital, this might be explained by pre-diagnostic examinations. In general practice, data suggest a bimodal structure with children later developing a relapse having more contacts also half a year before the relapse, suggesting that there could be early warnings. |
format | Online Article Text |
id | pubmed-8378397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83783972021-09-02 Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study Jensen, Karen Schow Klug Albertsen, Birgitte Schrøder, Henrik Zalounina Falborg, Alina Schmiegelow, Kjeld Rosthøj, Steen Callesen, Michael Thude Vedsted, Peter BMJ Open Haematology (Incl Blood Transfusion) OBJECTIVES: To investigate health care utilisation including both primary and secondary health care 6 months before the diagnosis of a relapse or a second malignant neoplasm (SMN) in survivors of childhood acute lymphoblastic leukaemia (ALL). DESIGN AND SETTING: A Danish population-based matched cohort study linking multiple nationwide registries. PARTICIPANTS: Participants were recruited from a total of 622 childhood ALL 2.5-year event-free survivors diagnosed between 1994 and 2015. Cases were survivors developing a relapse or an SMN and references were survivors still in first remission. Each case was matched with five references on age, sex, treatment protocol and risk group. PRIMARY OUTCOME MEASURES: Consultations in general practice and hospital the last 6 months before relapse or SMN. Cases and references were compared with monthly incidence rate ratios (IRRs) from negative binomial regression models. RESULTS: Of the 622 childhood ALL survivors, 60 (9.6%) developed a relapse (49) or an SMN (11) and 295 matched references were identified. Health care utilisation in general practice increased among cases the last month before the event compared with references with an IRR of 2.71 (95% CI 1.71 to 4.28). Data showed a bimodal structure with a significantly increased number of visits 4, 5 and 6 months before the event. Hospital health care utilisation increased 2 months before the event in cases with an IRR of 5.01 (3.78 to 6.63) the last month before the event and an IRR of 1.94 (1.32 to 2.85) the second-last month comparing cases and references. CONCLUSIONS: Survivors of childhood ALL developing a relapse or an SMN have a short period of increased health care utilisation before diagnosis. At hospital, this might be explained by pre-diagnostic examinations. In general practice, data suggest a bimodal structure with children later developing a relapse having more contacts also half a year before the relapse, suggesting that there could be early warnings. BMJ Publishing Group 2021-08-19 /pmc/articles/PMC8378397/ /pubmed/34413108 http://dx.doi.org/10.1136/bmjopen-2021-050285 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Haematology (Incl Blood Transfusion) Jensen, Karen Schow Klug Albertsen, Birgitte Schrøder, Henrik Zalounina Falborg, Alina Schmiegelow, Kjeld Rosthøj, Steen Callesen, Michael Thude Vedsted, Peter Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title | Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title_full | Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title_fullStr | Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title_full_unstemmed | Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title_short | Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
title_sort | health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study |
topic | Haematology (Incl Blood Transfusion) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378397/ https://www.ncbi.nlm.nih.gov/pubmed/34413108 http://dx.doi.org/10.1136/bmjopen-2021-050285 |
work_keys_str_mv | AT jensenkarenschow healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT klugalbertsenbirgitte healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT schrøderhenrik healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT zalouninafalborgalina healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT schmiegelowkjeld healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT rosthøjsteen healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT callesenmichaelthude healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy AT vedstedpeter healthcareutilisationprecedingrelapseorsecondmalignantneoplasmafterchildhoodacutelymphoblasticleukaemiaapopulationbasedmatchedcohortstudy |